Dr. Muhammad Rafiqul Islam is a licensed and dynamic Medical Oncology professional with six years of impactful service at a leading facility in Bangladesh, where he treats over 25,000 patients annually. Currently serving as an Assistant Professor and Clinical Researcher at the esteemed National Institute of Cancer Research and Hospital, his dedication to improving patient outcomes is evident through his superior clinical skills and a stellar reputation for patient service. Driven by a passion for advancing oncology care, he seeks a position where his wealth of knowledge and experiences can contribute significantly to the well-being of oncology patients and the advancements of the cancer center or unit. His proven track record in academia and clinical research positions him as an invaluable asset, ready to bring positive change to the field. Dr. Muhammad Rafiqul Islam's professional journey is marked by a rich tapestry of training experiences, reflecting a commitment to excellence in medical care. His advanced medical oncology training at TATA Memorial Hospital in India (May 20 - June 3, 2019) showcases a dedication to staying at the forefront of cutting-edge treatments. In April 2019, he furthered his expertise in healthcare innovation by participating in a training program on clinical trials for investigators at the National Institute of Cancer Research & Hospital in Bangladesh. Dr. Islam's holistic approach to patient well-being is evident in his extensive palliative and hospice care training with the Asia Pacific Hospice Care Network and Lien Collaborative in Singapore (July 2013 - March 2018). To enhance his teaching capabilities, he engaged in a program on teaching methodology covering pharmacology, pain management, and advanced rehabilitation medicine at the University of Malaysia Sarawak (January 14-20, 2018). His commitment to multidisciplinary patient care is underscored by his participation in Partners for World Health's program on the care of cancer patients in October 2017. Dr. Islam's foundational medical training includes a residency in medicine at the Department of Medicine, Sher-E-Bangla Medical College Hospital in Barisal, Bangladesh (April 5, 2011, to April 4, 2013). Beyond clinical expertise, his training portfolio extends to societal welfare, encompassing programs on handling victims of violence against women and the management of torture survivors. With a robust background in basic and advanced life support, Dr. Islam's multifaceted training equips him to make meaningful contributions to the healthcare landscape, reflecting a lifelong commitment to enhancing patient outcomes and well-being. Achievements and other activities: GeoHealth scholarship (NIH) MsPH, University of Chicago, USA 2013 JSMO-RISA (Rising Star in South Asia) Japanese Society of Medical Oncology (JSMO) 2023 Travel Grant JSMO Anural meeting (abstract accepted) 2023 Research Grant Director General of Health Services, Ministry of Health and Family Welfare, Bangladesh 2022 Palliative Care Doctor Award Hospice Bangladesh 2021 International Development and Education Award (IDEA) ASCO American society of clinical oncology (ASCO) 2020 Best Poster Award (public policy) European Society for Medical Oncology- Asia (ESMO) 2019 Best Poster Award Bangladesh International Cancer Congress (BICC), Oncology Club 2018 Organizing Secretary Medical Oncology Society in Bangladesh (MOSB) General Secretary Journal Club of Medical Oncology Founder Fellow Bangladesh Cancer Study Group Working Group member Global Breast Cancer Initiative (GBCI) Member European Society of Medical Oncology (ESMO) Member American Society of Clinical Oncology (ASCO) Member International Association for the study of lung cancer (IASLC) Member European Respiratory Society (ERS) Member American College of Physicians (ACP) Member Asia Pacific Hospice Care Network (APHN) Member Society of Geriatric Oncology (SIOG) 1. Islam MR, Siddiqua SM, Islam R, Hossain A, Al Ayub SB, Islam MS, et al. Lung Cancer in Bangladesh. Journal of Thoracic Oncology. 2023;18(8):972-80. 2. Saha B, Khatun N, Azim N, Islam SA, Proteek MF, Islam MR, et al. Platelet Count as a Prognostic Factor in Stage IV Non-Small Cell Lung Cancer. Mymensingh Med J. 2022;31(4):937-46. 3. Rizwan, F., Monjur, F., Rahman, M., Tamanna, S., Khan, N. M., Islam, M. R., Alam, S., & Mariyam, L. (2023). Burnout risks in Bangladeshi Physicians: A multicenter, cross-sectional study. Heliyon, 9(12), e22386. https://doi.org/10.1016/j.heliyon.2023.e22386 4. Islam MR, Hasan A, Khatun N, Ridi IN, Rasheed MMO, Islam SMA, et al. Demographic differentials of lung cancer survival in Bangladeshi patients. PloS one. 2021;16(12): e0261238. 5. Muhammad Rafiqul Islam; Doing What I Can, With What I Have, Where I Am: The Perspective of a Medical Oncologist in Bangladesh; Asco connection; June 22, 2021 6. Muhammad Rafiqul Islam; Urbanization in Bangladesh: The Prevalence of Breast Cancer brings unique challenges; https://ascopost.com/issues/october-25-2021. 7. Islam MR, Islam SMA, Khatun N, Begum FA: A young man presented with prostatic Rhabdomyosarcoma: A Case report; Cancer J Bangladesh. Vol. 1, No. 1: July 2020 8. Hasan ATMK, Islam MR, Alam MJ, Khan AAM, Hossain N, Asaduzzaman M; Socio-Demographic Factors of Stomach Cancer Patients Admitted in NICRH Cancer J Bangladesh. Vol. 1, No. 1: July 2020 9. Islam MR, Siddiqua SM, Haque S, Roy PK, Shefa J" A Clinico-Pathological Overview of Bone Metastasis of Solid Tumor at National Institute of Cancer Research & Hospital, Mohakhali, Dhaka"; European Academic Research Vol. VII, Issue 11/ February 2020, 10. Siddiqua SM, Haque S, Islam MR, Tahsin T, Sultana F, Shefa J "Osteoarthritis & Glycaemic Status among Type 2 Diabetes Mellitus Patients"; European Academic Research Vol. VI, Issue 12/ March 2020 11. Roy PK, Haque S, Siddiqua SM, Islam MR, Shefa J "Financial Burden of Lung Cancer Patients Attending Specialized Hospitals"; European Academic Research Vol. VII, Issue 11/ February 2020 12. Alam MJ, Khan AAM, Akhtar PS, Khatun N, Islam MR, A comparative study 5 Fu, leucovorin vs 5 fu, leucovorin and oxaliplatin in metastatic colon cancer in National institute of cancer Research & Hospital (NICRH), Dhaka. Bangladesh Oncology Journal; Vol 10 no 1&2; March 2019 p14-18